[PDF] Top 20 <p>Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects</p>
Has 10000 "<p>Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects</p>" found on our website. Below are the top 20 most common "<p>Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects</p>".
<p>Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects</p>
... Paediatric sarcoma constitutes a major group of disease that includes osteosarcoma (OGS), Ewing ’ s sarcoma/primitive neuroectodermal tumor (EWS/PNET), rhabdo- myosarcoma (RMS), and heterogeneous group of ... See full document
20
<p>Management Of Excessive Sleepiness In Patients With Narcolepsy And OSA: Current Challenges And Future Prospects</p>
... Availability of CSF hypocretin testing is forthcoming in the United States, but the cost of testing and performing the lumbar puncture is unknown and there are risks associated with the procedure itself. To date, there ... See full document
12
Pediatric ventricular assist devices: current challenges and future prospects
... Although pediatric mechanical circulatory support has lagged behind that of adults, the gap between them is expected to close ...result, pediatric centers have just started implanting adult intracorporeal ... See full document
9
Pediatric neurocysticercosis: current challenges and future prospects
... of the developing countries, it is also seen in many developed countries due to the immigrant population from endemic areas and increasing international travel. NCC in children has pleomorphic manifestations depending on ... See full document
12
<p>Living with Narcolepsy: Current Management Strategies, Future Prospects, and Overlooked Real-Life Concerns</p>
... present challenges both to women with narcolepsy when facing decisions concerning family planning as well as to physicians treating this population of narcolepsy ...99,100 Challenges for women with nar- ... See full document
14
Diabetic gastroparesis: current challenges and future prospects
... coagulation current, 35 W) using a Triangle Knife (Olympus, Tokyo, ...of refractory gastroparesis: clinical experience with follow-up and scintigraphic evaluation (with video), 132–139, Copyright (2017), ... See full document
17
Neurotrophic keratitis: current challenges and future prospects
... perforation. Management of NK is based on clinical severity, and the aim of the therapy is to halt the progression of corneal damage and promote epithelial ... See full document
9
Hepatic encephalopathy: current challenges and future prospects
... The management of HE has evolved over the last 10 years with the addition on rifaximin into current treatment guidelines. There has been an increase in the number of randomized controlled trials with ... See full document
11
<p>Refractory Kawasaki disease: diagnostic and management challenges</p>
... of refractory KD and thus CAAs is a research priority in order to identify high-risk patients early in the disease course who may bene fi t from more aggressive ...the future, a risk score may include ... See full document
9
<p>Management of recurrent Ewing sarcoma: challenges and approaches</p>
... Ewing sarcoma remains poor, and the standard approach to their management has not yet been ...the future. In this regard, close coopera- tion between pediatric and adult oncology centers, as ... See full document
10
<p>BRCA Mutations in Pancreas Cancer: Spectrum, Current Management, Challenges and Future Prospects</p>
... Abstract: Pancreatic ductal adenocarcinoma (PDAC) remains a challenging disease to treat. Despite advances in surgical techniques, radiation, and medical therapies, the 5-year survival rate remains below 9%. Over the ... See full document
12
<p>Refractory Metastatic Colorectal Cancer: Current Challenges and Future Prospects</p>
... Increasing numbers of patients with mCRC maintain good performance status even with disease progression, and seek active anti-cancer treatment in the third- and fourth-line setting and beyond. There have been relatively ... See full document
12
<p><em>IDH1</em>-mutated relapsed or refractory AML: current challenges and future prospects</p>
... Abstract: The prognosis of patients with relapsed or refractory acute myeloid leukemia (R/R AML) is discouraging with salvage standard approaches. Mutations of isocitrate dehydrogenase 1 (IDH1 mut ), present in 7 ... See full document
14
<p>Chlorhexidine Allergy: Current Challenges and Future Prospects</p>
... the future. Appropriate diagnosis and management of these patients may lead to better outcomes, and future reactions may be ...The management to avoid re-exposure in the patients with proven ... See full document
7
<p>Hepatorenal Syndrome Type 1: Current Challenges And Future Prospects</p>
... Vasoconstrictors actually in use for the management of HRS are: terlipressin, noradrenaline and the combination of midodrine + octreotide. Terlipressin represents the most used and tested drug in the therapeutic ... See full document
9
Hand transplantation: current challenges and future prospects
... The psychological and physical impact of losing an upper extremity is profound. Such a loss results in significant dis- ability, with severe impact on quality of life. The mainstay of treatment for hand amputation has ... See full document
7
<p>Overview, Challenges and Future Prospects of Drug Information Services in Nepal: A Reflective Commentary</p>
... Nepal, challenges for DIC, how DICs can be strengthened and future perspectives of ...the future to provide quality health care service to the ... See full document
9
<p>Current status and future prospects of PARP inhibitor clinical trials in ovarian cancer</p>
... PARP inhibitor maintenance therapy achieved substan- tial PFS bene fi t among patients with platinum-sensitive recurrent ovarian cancer after a CR/PR to the most recent regimen. SOLO1 demonstrated that olaparib ... See full document
20
<p>Biliary tract cancers: current knowledge, clinical candidates and future challenges</p>
... The role of immunomodulating treatments in BTC is still an area of exploration, and none of the current immune inves- tigational drugs have been approved in this disease group. The expression of PD-L1 is a ... See full document
20
Recurrent pericarditis: current challenges and future prospects
... streptokinase, p-aminosalicylic acid, sulfa drugs, cyclosporine, bromocriptine, several vaccines, and anti-tumor necrosis factor [TNF] agents) secondary to chemotherapy (anthracycline derivatives, 5-fluorouracil, ... See full document
10
Related subjects